NYSE:CO Global Cord Blood (CO) Stock Price, News & Analysis → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free CO Stock Alerts $1.10 -0.10 (-8.33%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$1.10▼$1.1050-Day Range$1.10▼$1.5052-Week Range$2.03▼$5.50Volume125 shsAverage Volume216,519 shsMarket Capitalization$133.71 millionP/E Ratio1.72Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends Get Global Cord Blood alerts: Email Address Ad Crypto 101 Media[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Global Cord Blood Stock (NYSE:CO)Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More CO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CO Stock News HeadlinesMay 30 at 1:24 AM | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Now Covered by StockNews.comMay 28 at 9:29 PM | stockhouse.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global CordMay 28 at 4:29 PM | msn.comTusla reports doubling of children in State care who may have been targeted for sexual exploitationMay 22, 2024 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Earns Strong-Buy Rating from Analysts at StockNews.comMay 22, 2024 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Share Price Crosses Above 200-Day Moving Average of $1.36May 21, 2024 | finance.yahoo.comGlobal Cord Blood Corporation (CORBF)May 20, 2024 | prnewswire.comROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 14, 2024 | msn.comAbu Dhabi to establish region's first public cord blood biobank in Masdar CityMay 14, 2024 | msn.comAbu Dhabi to establish region's first biobank in Masdar CityMay 13, 2024 | prnewswire.comROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 7, 2024 | businesswire.comCO Stockholders with Significant Losses Should Contact Robbins LLP for Information About the Global Cord Blood Corporation Securities Class ActionMay 6, 2024 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 6, 2024 | stockhouse.comThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) InvestorsMay 4, 2024 | markets.businessinsider.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global CordMay 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global CordMay 1, 2024 | stockhouse.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global CordApril 30, 2024 | finance.yahoo.comForge Biologics Announces Nine Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingApril 30, 2024 | msn.comInside the Makeshift Maternity Wards of HarareApril 29, 2024 | tmcnet.comThe Law Offices of Frank R. Cruz Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of InvestorsApril 28, 2024 | markets.businessinsider.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global CordApril 27, 2024 | msn.com50,000-Year-Old Tiara Made From Woolly Mammoth Tusk Unearthed In Siberian CaveApril 26, 2024 | prnewswire.comROSEN, A RANKED AND LEADING FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFApril 26, 2024 | businesswire.comGlobal Cord Blood Corporation (CO) Investor Notice: Robbins LLP Reminds Stockholders of the Global Cord Blood Corporation Class ActionApril 26, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global CordApril 24, 2024 | businesswire.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Global Cord Blood Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBFSee More Headlines Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/26/2018Today5/29/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1.72 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.11 Cash Flow$0.26 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.17Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$133.71 million OptionableNo Data Beta0.16 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesTing ZhengChairman & Chief Executive OfficerBing Chuen ChenChief Financial Officer & DirectorXin XuChief Technology OfficerRui ArashiyamaCEO-Guangdong & Zhejiang DivisionsKey CompetitorsViemed HealthcareNASDAQ:VMDGlobal Cord BloodNYSE:CORBFOntrakNASDAQ:OTRKMangoceuticalsNASDAQ:MGRXMarpaiNASDAQ:MRAIView All Competitors CO Stock Analysis - Frequently Asked Questions How have CO shares performed in 2024? Global Cord Blood's stock was trading at $1.22 at the start of the year. Since then, CO shares have decreased by 9.8% and is now trading at $1.10. View the best growth stocks for 2024 here. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) issued its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Is Global Cord Blood a good dividend stock? Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CO. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL). How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CO) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.